In gefitinib-resistant NSCLC cells, MMP-12 was inhibited through suppression of the EGFR/ERK signaling pathway, thus inhibited cell proliferation, invasion, and migration (48). This evidence concerns the gene MMP12 and non-small cell lung carcinoma.